Namensänderung -- Cannabis Wheaton name change to Auxly Cannabis (Seite 123)
eröffnet am 15.05.17 16:04:27 von
neuester Beitrag 28.03.24 16:04:05 von
neuester Beitrag 28.03.24 16:04:05 von
Beiträge: 2.141
ID: 1.252.934
ID: 1.252.934
Aufrufe heute: 0
Gesamt: 394.980
Gesamt: 394.980
Aktive User: 0
ISIN: CA05335P1099 · WKN: A2JNSX · Symbol: 3KF
0,0358
EUR
0,00 %
0,0000 EUR
Letzter Kurs 25.04.24 Tradegate
Werte aus der Branche Finanzdienstleistungen
Wertpapier | Kurs | Perf. % |
---|---|---|
15,000 | +900,00 | |
7,5000 | +50,00 | |
25,50 | +42,86 | |
0,9000 | +20,00 | |
0,5300 | +17,78 |
Wertpapier | Kurs | Perf. % |
---|---|---|
1,5000 | -23,08 | |
1,0500 | -23,36 | |
3,0000 | -24,91 | |
1,5000 | -40,00 | |
4,8850 | -50,53 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 56.554.855 von Cascadeur am 27.12.17 23:39:42Nach der wideraufnahme des Handels hatte ich mit kleinen Gewinn verkauft und mir das Schauspiel wie die KE angenommen wird von der Seitenlinie angeschaut am gleichen Abend wieder gekauft
Antwort auf Beitrag Nr.: 56.554.555 von Edison09 am 27.12.17 22:21:21Ich dachte du bist am 22.12. mit leichtem Verlust ausgestiegen.
Doch wieder eingestiegen?
Doch wieder eingestiegen?
Antwort auf Beitrag Nr.: 56.554.477 von strongbuyamitelo am 27.12.17 22:09:14Bevor wir uns über den Freitag sorgen freuen wir uns erstmal auf Donnerstag mein Tipp Eröffnung über 2cad
Schlusskurs: 1.78.
Fast auf Tageshoch geschlossen. Hoffe nicht, dass es am Freitag zum Abverkauf kommt. Bin aber sehr zufrieden mit dem Verlauf.
Fast auf Tageshoch geschlossen. Hoffe nicht, dass es am Freitag zum Abverkauf kommt. Bin aber sehr zufrieden mit dem Verlauf.
Das sieht sehr gut aus definitiv Long
Antwort auf Beitrag Nr.: 56.553.751 von lamaro am 27.12.17 20:37:15
Entweder einen Link zufügen. Oder der Beitrag muss gelöscht werden.
Zitat von lamaro: angeblich ein deal mit enwave stattfinden
Entweder einen Link zufügen. Oder der Beitrag muss gelöscht werden.
!
Dieser Beitrag wurde von MagicMOD moderiert. Grund: Fehlende Quellenangabe
CANNABIS WHEATON INCOME CORP. ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT WITH
STREAMING PARTNER CANNTX LIFE SCIENCES INC.
News Release
Vancouver, British Columbia, December 22, 2017 – Cannabis Wheaton Income Corp. (d/b/a Wheaton
Income) (TSX.V - CBW) ("Wheaton Income" or the "Company") is pleased to announce that further to
its previously announced interim agreement, it has entered into a definitive agreement (the
"Agreement") with its streaming partner CannTx Life Sciences Inc. ("CannTx") to fund the construction
of its cannabis production facility located in Puslinch, Ontario (the "Facility"). CannTx is a privatelyowned
company that has applied to become a licensed producer under the Access to Cannabis for
Medical Purposes Regulations (the "Application"). Health Canada has confirmed that it has completed
its paper-review of the Application and that CannTx needs to submit a "confirmation of readiness" to
demonstrate that the Facility is eligible for licensing.
Pursuant to the Agreement, the Company will provide CannTx with $5,000,000 related to the initial
costs for the phase I construction of the Facility, which is currently estimated to be 13,120 square feet.
In addition, the Company will provide CannTx with $7,000,000 related to the phase II expansion of the
Facility, subject to the Company completing satisfactory due diligence and the parties agreeing to a
construction budget and timeline for the phase II expansion. The phase II expansion is expected to
increase the cultivation area of the Facility to effectively 24,000 square feet of pure cultivation space
by using innovative vertical grow technology.
In consideration for the financing, the Company will receive a minority equity interest in CannTx and an
entitlement to 33% of all cannabis (or cannabis-derived products including any cannabis trim) produced
at the Facility for a period of 10 years from the date of first sale at a fixed cost.
Hugo Alves, President of Wheaton Income commented, "We've gotten to know the CannTx team really
well over the past six months and we are looking forward to watching them execute on their cultivation
strategy. Mike, Buck, Josh and the entire CannTx team are thoughtful, passionate and professional
entrepreneurs that we feel are going to be hugely successful in the industry and we are proud to be a
part of this story. This investment further enhances our platform by adding to our cultivation capacity,
diversifying our product mix and welcoming another incredible team to the Wheaton family. "
Mike Abbott, President and CEO of CannTx said, “Everybody at CannTx Life Sciences feels privileged to
be the first example of the Wheaton model. Drawing on the expertise of the entire Wheaton team
significantly de-risks our execution and helps us realize our ambitious objectives. We have made
tremendous progress toward commercializing biotechnologies which aim to disrupt the cannabis
industry. The opportunity to join Wheaton’s innovative platform grants exposure for our technology
and services, which we believe have the potential to enhance the value of Wheaton and its other
streaming partners.”
ON BEHALF OF THE BOARD
"Chuck Rifici" Chairman & CEO
About Wheaton Income. (TSX.V: CBW)
Wheaton Income is a collective of entrepreneurs with a passion for the cannabis industry past,
present and future. Our mandate is to facilitate growth for our partners by providing them with
financial support and sharing our collective industry experience. Our partners all have different
visions, voices and brand values, and all share a common goal—to build a world-class industry based
on ethics, diversity, quality and innovation.
Stay Connected:
For more information about Wheaton Income and our management team, please visit:
http://www.cannabiswheaton.com, or follow us on Twitter @WheatonIncome. Call: 1.604.687.7130
Email: Mario@skanderbegcapital.com (http://www.skanderbegcapital.com).
Media Contact:
Sarah Bain, VP External Affairs
Email: sarah@cannabiswheaton.com
Phone: 613.230.5869
About CannTx.
CannTx is a privately-owned company that has applied to become a licensed producer of cannabis
under the Access to Cannabis for Medical Purposes Regulations. CannTx is positioned to become a
leader in the cannabis industry. Through its unique cultivation techniques, CannTx is focused on
achieving unparalleled consistency, resulting in higher quality cannabis products, and yielding greater
market penetration. The experienced management team at CannTx brings a diverse set of core
competencies and a new level of sophistication and capability to the industry. CannTx will utilize its
unique human capital and licensing of proprietary technology to drive lower costs without sacrificing
quality.
Stay Connected:
For more information about CannTx and its management team, please visit: http://www.canntx.com
or contact Josh Gerstein, Vice-President of Corporate Development at 1.416.459.6900 or by email at
josh.gerstein@canntx.com.
Notice Regarding Forward Looking Statements:
This news release contains certain "forward-looking information" within the meaning of applicable
Canadian securities law. Forward-looking information is frequently characterized by words such as
"plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or information that certain events or conditions "may"
or "will" occur. This information is only a prediction. Various assumptions were used in drawing the
conclusions or making the projections contained in the forward-looking information throughout this
news release. Forward-looking information includes, but is not limited to: CannTx's ability to obtain a
cultivation license and the related timing considerations, CannTx's ability to satisfy the conditions
associated with its cultivation license, CannTx's ability to obtain a sales authorization for the license and
the related timing considerations, the completion of the Facility and the related timing considerations;
the Company’s ability to generate revenue through the Agreement, requirements to obtain additional
financing, timeliness of government approvals for granting of permits and licenses, actual operating
performance of the Facility, regulatory or political change, competition and other risks affecting the
Company in particular and the cannabis industry generally. Forward-looking information is based on
the opinions and estimates of management at the date the information is made, and is subject to a
variety of risks and uncertainties and other factors that could cause actual events or results to differ
materially from those projected in the forward-looking information. The Company is not under any
obligation, and expressly disclaims any intention or obligation, to update or revise any forward -looking
information, whether as a result of new information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this
releas
https://sedar.com/GetFile.do?lang=EN&docClass=8&issuerNo=000…
STREAMING PARTNER CANNTX LIFE SCIENCES INC.
News Release
Vancouver, British Columbia, December 22, 2017 – Cannabis Wheaton Income Corp. (d/b/a Wheaton
Income) (TSX.V - CBW) ("Wheaton Income" or the "Company") is pleased to announce that further to
its previously announced interim agreement, it has entered into a definitive agreement (the
"Agreement") with its streaming partner CannTx Life Sciences Inc. ("CannTx") to fund the construction
of its cannabis production facility located in Puslinch, Ontario (the "Facility"). CannTx is a privatelyowned
company that has applied to become a licensed producer under the Access to Cannabis for
Medical Purposes Regulations (the "Application"). Health Canada has confirmed that it has completed
its paper-review of the Application and that CannTx needs to submit a "confirmation of readiness" to
demonstrate that the Facility is eligible for licensing.
Pursuant to the Agreement, the Company will provide CannTx with $5,000,000 related to the initial
costs for the phase I construction of the Facility, which is currently estimated to be 13,120 square feet.
In addition, the Company will provide CannTx with $7,000,000 related to the phase II expansion of the
Facility, subject to the Company completing satisfactory due diligence and the parties agreeing to a
construction budget and timeline for the phase II expansion. The phase II expansion is expected to
increase the cultivation area of the Facility to effectively 24,000 square feet of pure cultivation space
by using innovative vertical grow technology.
In consideration for the financing, the Company will receive a minority equity interest in CannTx and an
entitlement to 33% of all cannabis (or cannabis-derived products including any cannabis trim) produced
at the Facility for a period of 10 years from the date of first sale at a fixed cost.
Hugo Alves, President of Wheaton Income commented, "We've gotten to know the CannTx team really
well over the past six months and we are looking forward to watching them execute on their cultivation
strategy. Mike, Buck, Josh and the entire CannTx team are thoughtful, passionate and professional
entrepreneurs that we feel are going to be hugely successful in the industry and we are proud to be a
part of this story. This investment further enhances our platform by adding to our cultivation capacity,
diversifying our product mix and welcoming another incredible team to the Wheaton family. "
Mike Abbott, President and CEO of CannTx said, “Everybody at CannTx Life Sciences feels privileged to
be the first example of the Wheaton model. Drawing on the expertise of the entire Wheaton team
significantly de-risks our execution and helps us realize our ambitious objectives. We have made
tremendous progress toward commercializing biotechnologies which aim to disrupt the cannabis
industry. The opportunity to join Wheaton’s innovative platform grants exposure for our technology
and services, which we believe have the potential to enhance the value of Wheaton and its other
streaming partners.”
ON BEHALF OF THE BOARD
"Chuck Rifici" Chairman & CEO
About Wheaton Income. (TSX.V: CBW)
Wheaton Income is a collective of entrepreneurs with a passion for the cannabis industry past,
present and future. Our mandate is to facilitate growth for our partners by providing them with
financial support and sharing our collective industry experience. Our partners all have different
visions, voices and brand values, and all share a common goal—to build a world-class industry based
on ethics, diversity, quality and innovation.
Stay Connected:
For more information about Wheaton Income and our management team, please visit:
http://www.cannabiswheaton.com, or follow us on Twitter @WheatonIncome. Call: 1.604.687.7130
Email: Mario@skanderbegcapital.com (http://www.skanderbegcapital.com).
Media Contact:
Sarah Bain, VP External Affairs
Email: sarah@cannabiswheaton.com
Phone: 613.230.5869
About CannTx.
CannTx is a privately-owned company that has applied to become a licensed producer of cannabis
under the Access to Cannabis for Medical Purposes Regulations. CannTx is positioned to become a
leader in the cannabis industry. Through its unique cultivation techniques, CannTx is focused on
achieving unparalleled consistency, resulting in higher quality cannabis products, and yielding greater
market penetration. The experienced management team at CannTx brings a diverse set of core
competencies and a new level of sophistication and capability to the industry. CannTx will utilize its
unique human capital and licensing of proprietary technology to drive lower costs without sacrificing
quality.
Stay Connected:
For more information about CannTx and its management team, please visit: http://www.canntx.com
or contact Josh Gerstein, Vice-President of Corporate Development at 1.416.459.6900 or by email at
josh.gerstein@canntx.com.
Notice Regarding Forward Looking Statements:
This news release contains certain "forward-looking information" within the meaning of applicable
Canadian securities law. Forward-looking information is frequently characterized by words such as
"plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will",
"potential", "proposed" and other similar words, or information that certain events or conditions "may"
or "will" occur. This information is only a prediction. Various assumptions were used in drawing the
conclusions or making the projections contained in the forward-looking information throughout this
news release. Forward-looking information includes, but is not limited to: CannTx's ability to obtain a
cultivation license and the related timing considerations, CannTx's ability to satisfy the conditions
associated with its cultivation license, CannTx's ability to obtain a sales authorization for the license and
the related timing considerations, the completion of the Facility and the related timing considerations;
the Company’s ability to generate revenue through the Agreement, requirements to obtain additional
financing, timeliness of government approvals for granting of permits and licenses, actual operating
performance of the Facility, regulatory or political change, competition and other risks affecting the
Company in particular and the cannabis industry generally. Forward-looking information is based on
the opinions and estimates of management at the date the information is made, and is subject to a
variety of risks and uncertainties and other factors that could cause actual events or results to differ
materially from those projected in the forward-looking information. The Company is not under any
obligation, and expressly disclaims any intention or obligation, to update or revise any forward -looking
information, whether as a result of new information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this
releas
https://sedar.com/GetFile.do?lang=EN&docClass=8&issuerNo=000…
Heute wäre schön aber glaube ich nicht.
KE wurde besser als erwartet verdaut jetzt ist die Angst raus könnte kurzfristig bis 3cad laufen langfristig ist hier erheblich mehr Potenzial drin.
KE wurde besser als erwartet verdaut jetzt ist die Angst raus könnte kurzfristig bis 3cad laufen langfristig ist hier erheblich mehr Potenzial drin.
Sieht sehr gut aus. Könnten die 2 KD heute knacken.